EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Society for Maternal‐Fetal Medicine Special Statement: Updated checklists for preeclampsia risk‐factor screening to guide recommendations for prophylactic low‐dose aspirin

Society for Maternal‐Fetal Medicine (SMFM), Jeny Ghartey, C Andrew Combs, SMFM Patient Safety and Quality Committee

Pregnancy · 2026-03 · 2 (2)

DOI: 10.1002/pmf2.70212 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pregnancy, online erschienen am 04.02.2026. Verfasst von Society for Maternal‐Fetal Medicine (SMFM) und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prophylactic low‐dose aspirin is recommended to reduce the risk of preeclampsia in pregnant persons with risk factors. Sixteen distinct risk factors are recognized, including elements of current and past medical and obstetrical history, family history, and examination findings. In 2020, the Society for Maternal‐Fetal Medicine published checklists intended to reduce the chance that risk factors might be inadvertently overlooked and to improve the probability of aspirin being recommended for all appropriate candidates. In 2021, the U.S. Preventive Services Taskforce published an updated Recommendation Statement expanding the number of persons for whom aspirin prophylaxis is recommended. Here, the Society for Maternal‐Fetal Medicine presents updated checklists incorporating the new recommendations. We also suggest steps for implementing such a checklist into routine practice. This statement replaces the 2020 Society for Maternal‐Fetal Medicine Special Statement: Checklists for preeclampsia risk‐factor screening to guide recommendations for prophylactic low‐dose aspirin.

Schlagwörter

Stichwörter der Autor:innen

antiphospholipid syndromeautoimmune disordersdiabeteshypertensionimplementationin vitro fertilizationkidney diseasemultifetal pregnancypreventionsystemic lupus erythematosus

Zitieren

APA

Society for Maternal‐Fetal Medicine (SMFM), Ghartey, J., Combs, C. A., & SMFM Patient Safety and Quality Committee (2026). Society for Maternal‐Fetal Medicine Special Statement: Updated checklists for preeclampsia risk‐factor screening to guide recommendations for prophylactic low‐dose aspirin. Pregnancy, 2(2). https://doi.org/10.1002/pmf2.70212

Vancouver

Society for Maternal‐Fetal Medicine (SMFM), Ghartey J, Combs CA, SMFM Patient Safety and Quality Committee. Society for Maternal‐Fetal Medicine Special Statement: Updated checklists for preeclampsia risk‐factor screening to guide recommendations for prophylactic low‐dose aspirin. Pregnancy. 2026;2(2). doi:10.1002/pmf2.70212

BibTeX
@article{SocietyforMaternalFetalMedicineSMFM2026,
  author = {Society for Maternal‐Fetal Medicine (SMFM), Society for Maternal‐Fetal Medicine (SMFM) and Ghartey, Jeny and Combs, C Andrew and SMFM Patient Safety and Quality Committee, SMFM Patient Safety and Quality Committee},
  title = {Society for Maternal‐Fetal Medicine Special Statement: Updated checklists for preeclampsia risk‐factor screening to guide recommendations for prophylactic low‐dose aspirin},
  journal = {Pregnancy},
  year = {2026},
  volume = {2},
  number = {2},
  doi = {10.1002/pmf2.70212}
}
Kostenlos starten →